The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
about
Six months therapy for tuberculous meningitisM. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania.Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.Assessing tuberculosis case fatality ratio: a meta-analysis.Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.Drug-resistant tuberculosis in Africa.Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessmentPredictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia.Timing, rates, and causes of death in a large South African tuberculosis programme.Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in UgandaDouble blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained SettingsTuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.Association of Body Mass Index with Timing of Death during Tuberculosis Treatment.Tuberculosis and HIV infection: the global setting.Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana.New tuberculosis drug development: targeting the shikimate pathway.A new, clinically-based algorithm for the diagnosis of HIV in African tuberculosis patients: cross-sectional analysis from Mzuzu, Malawi.Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak.Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi.The prevalence of HIV in the sudden, unexplained and unexpected death population at the Pretoria Medico-Legal Laboratory.
P2860
Q28074247-041982D2-0579-43A5-BB35-7DE728BECAC6Q33286329-AD77B029-BA26-459C-B13F-1402FDA645D5Q33320707-440A5474-070F-4554-9F31-9E93423476FEQ33515849-A79CD9C2-B00A-40BA-8175-FC775A986314Q33813159-8D75F4AC-A31C-4175-8337-17D3DA1FAF40Q33884068-14CC1C70-6E28-410F-8503-584042B844BBQ33954598-D2D4291B-CD71-4CB4-B90C-033E1FD51F5EQ34438327-6929875E-D021-4DBC-8C07-09ADDB5A98B3Q34497239-4377972E-E2E8-4CD0-B6FD-CAA23F1537FEQ34554218-8967BFB5-0791-4215-BC0F-A33C41B3ED5DQ34560360-EB110F71-F0C9-4ABA-8F17-073543219E92Q34951938-37008045-5947-4687-80E9-D0730F6D91D8Q34979324-5E676E8B-4D1D-4891-A651-B2E1133103BAQ34989654-F8D705E2-D253-4A18-AF5E-7905148ED337Q35567001-216F9D19-70B7-4432-AFC8-AC706C1664EDQ35598520-E89C7DA2-6041-46C4-B728-EA34D8151241Q35647887-4196687A-1272-4F9F-B23A-54999441E44AQ36207851-B9873B6A-6B07-4B01-AD08-138821C5192AQ36248990-90960695-5A69-4BD9-B82F-345F624BC54DQ36877229-67CD57C9-BC97-4261-972F-C400A7EDFC49Q37008635-F144AEB7-3D72-4427-A52D-4389DB58C868Q38088794-4974C2ED-105F-42E7-AE8C-1783BE8D30EAQ39603987-8A5C7EC0-D1E5-4ABE-AD3D-93544DBC414FQ44183258-14F9F3EE-7B4B-4BC1-8CEB-64FA5490FAF4Q46432745-F5F8EC3D-FD76-4B22-AF93-5612DB610A29Q53761868-4C139EB3-5FDC-48FE-9EA8-BB78B7101C4A
P2860
The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The impact of human immunodefi ...... s in a cohort study in Zambia.
@en
type
label
The impact of human immunodefi ...... s in a cohort study in Zambia.
@en
prefLabel
The impact of human immunodefi ...... s in a cohort study in Zambia.
@en
P2093
P1476
The impact of human immunodefi ...... s in a cohort study in Zambia.
@en
P2093
A G Mwinga
A M Elliott
B Halwiindi
G Steenbergen
L Machiels
P356
10.1016/0035-9203(95)90668-1
P577
1995-01-01T00:00:00Z